ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-TCR gamma/delta Antibody [B1] (A279739)

This product is discontinued

Anti-TCR gamma/delta Antibody [B1] (A279739) has been discontinued and is no longer available.

View all available products.

Name
Anti-TCR gamma/delta Antibody [B1]
Description
Mouse monoclonal [B1] antibody to TCR gamma/delta.
Specificity
This antibody recognises TCR gamma/delta, a T cell receptor expressed by a small subset of T cells. In healthy individuals these TCR gamma/delta cells account for 1-10% of peripheral blood lymphocytes. TCR gamma/delta is composed of disulfide bonded gamma and delta chains that can bind directly to pathogen derived glycoprotein's or non-classical MHC molecules on tumor cells. This clone B1 has been used as a blocking antibody in experiments to examine the recognition of tumor cells by TCR gamma/delta cells. These experiments supported the hypothesis that innate NK receptors on gamma/delta cells can also bind and recognize tumor cells.
Applications
Flow Cytometry, IHC-Fr, IHC-P, Functional Assays
Reactivity
Human, Primate
Host
Mouse
Clonality
Monoclonal
Clone ID
B1
Isotype
IgG1
Conjugate

Unconjugated

Purification
Protein A affinity chromatography of tissue culture supernatant and 0.2µM filter sterilized.
Concentration
1 mg/ml
Purity
>95% (by SDS-PAGE).
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline.
Storage
Store undiluted at 4°C. Do not freeze!
General Notes
Mouse anti Human TCR gamma/delta, clone B1 recognizes TCR gamma/delta, a T cell receptor expressed by a small subset of T cells. In healthy individuals these TCR gamma/delta cells account for 1-10% of peripheral blood lymphocytes (Gomes et al. 2010). TCR gamma/delta is composed of disulfide bonded gamma and delta chains that can bind directly to pathogen derived glycoprotein's or non-classical MHC molecules on tumor cells (Kuhns et al. 2006). This clone B1 has been used as a blocking antibody in experiments to examine the recognition of tumor cells by TCR gamma/delta cells. These experiments supported the hypothesis that innate NK receptors on gamma/delta cells can also bind and recognize tumor cells (Correia et al. 2011).
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.